For the second year running, Denmark’s biotech sector is awarded a global top three ranking by Scientific American Worldview and is praised for its generous public sector investment and speedy drug trial application process.
Denmark takes the global top three spot in the 2016 Scientific American Worldview Scorecard, assessing countries worldwide according to their biotechnology innovation potential, ahead of its European contemporaries.
Denmark gets the top score for intensity, boasting 215.4 international patent applications filed per million inhabitants. When compared to Europe’s four largest economies, Denmark’s productive patent filling puts the country ahead of the UK, France and the Netherlands, second only to Germany.
Source: Invest in Denmark